R. Aliotta

Asymptomatic pulmonary congestion and physical functioning in hemodialysis patients.

C. Zoccali, M. Postorino, F. Mallamaci, 2013, Clinical journal of the American Society of Nephrology : CJASN.

Pancreatitis Is a Silent Killer in Peritoneal Dialysis With Difficult Diagnostic Approach

F. Rapisarda, S. Rastelli, R. Aliotta, 2018, Clinical medicine insights. Case reports.

Sparsentan in patients with IgA nephropathy: a prespecified interim analysis from a randomised, double-blind, active-controlled clinical trial

Eddie B. S. Tan, Nishit P. Parikh, Rajan K. Patel, 2023, The Lancet.

Pro-inflammatory cytokines and bone fractures in CKD patients. An exploratory single centre study

C. Zoccali, F. Mallamaci, G. Tripepi, 2012, BMC Nephrology.

Efficacy and safety of sparsentan versus irbesartan in patients with IgA nephropathy (PROTECT): 2-year results from a randomised, active-controlled, phase 3 trial

N. Perico, M. Jardine, V. Perkovic, 2023, The Lancet.

[Magnesium, calcium and potassium: "no one was born alone"].

P. Fatuzzo, F. Rapisarda, G. Portale, 2016, Giornale italiano di nefrologia : organo ufficiale della Societa italiana di nefrologia.